This inventor holds 1 USPTO granted patent. Top assignee: Beijing Friendship Hospital, Capital Medical University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Junhao Wei in Biomedicine
Introduction
Junhao Wei is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedicine, particularly in the area of drug resistance prediction.
Latest Patents
Junhao Wei holds a patent titled "Biomarker for predicting drug resistance of bruton's tyrosine kinase inhibitors and application thereof." This patent provides a biomarker for predicting drug resistance of a BTK inhibitor, specifically relating to diffuse large B cell lymphoma cells. The biomarker identified in this patent is either SMPD1 or SPHK1. This innovation is crucial for predicting the sensitivity of these lymphoma cells to BTK inhibitors, which can greatly impact treatment outcomes. He has 1 patent to his name.
Career Highlights
Junhao Wei is affiliated with Beijing Friendship Hospital, Capital Medical University. His work in this institution has allowed him to focus on groundbreaking research in biomedicine, contributing to advancements in cancer treatment.
Collaborations
He has collaborated with notable colleagues, including Yiqun Che and Xinyu Han, to further enhance the research and application of his innovations.
Conclusion
Junhao Wei's work in developing biomarkers for drug resistance represents a significant advancement in the field of biomedicine. His contributions are poised to improve treatment strategies for patients with diffuse large B cell lymphoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile